Returns samples from the posterior distributions of each model parameter using WinBUGS
Returns samples from the posterior distributions of each model parameter using WinBUGS
If ff = "logit2" (i.e. a two-parameter logistic model is used), a matrix of dimensions production.itr-by-2 is returned (the first and second columns containing the posterior samples for the intercept and slope parameters respectively). Otherwise, a vector of length production.itr
tox: A vector of length k showing the number of patient who had toxicities at each dose level
notox: A vector of length k showing the number of patients who did not have toxicities at each dose level
sdose: A vector of length k listing the standardised doses to be used in the CRM model.
ff: A string indicating the functional form of the dose-response curve. Options are
ht: 1-parameter hyperbolic tangent
logit1: 1-parameter logistic
power: 1-parameter power
logit2: 2-parameter logistic
prior.alpha: A list of length 3 containing the distributional information for the prior. The first element is a number from 1-4 specifying the type of distribution. Options are
Gamma(a, b), where a=shape, b=scale: mean=ab, variance=ab*b
Uniform(a, b), where a=min, b=max
Lognormal(a, b), where a=mean on the log scale, b=variance on the log scale
Bivariate Lognormal(a, b), where a=mean vector on the log scale, b=Variance-covariance matrix on the log scale. This prior should be used only in conjunction with a two-parameter logistic model.
The second and third elements of the list are the parameters a and b, respectively.
burnin.itr: Number of burn-in iterations (default 2000).
production.itr: Number of production iterations (default 2000).
bugs.directory: directory that contains the WinBUGS executable, defaults to C:/Program Files/WinBUGS14/
Examples
## Dose-escalation cancer trial example as described in Neuenschwander et al 2008.## Pre-defined dosesdose <- c(1,2.5,5,10,15,20,25,30,40,50,75,100,150,200,250)## Pre-specified probabilities of toxicity## [dose levels 11-15 not specified in the paper, and are for illustration only]p.tox0 <- c(0.010,0.015,0.020,0.025,0.030,0.040,0.050,0.100,0.170,0.300,0.400,0.500,0.650,0.800,0.900)## Data from the first 5 cohorts of 18 patientstox <- c(0,0,0,0,0,0,2,0,0,0,0,0,0,0,0)notox <- c(3,4,5,4,0,0,0,0,0,0,0,0,0,0,0)## Target toxicity leveltarget.tox <-0.30## Prior distribution for the MTD given a lognormal(0, 1.34^2) distribution for alpha## and a power model functional formprior.alpha <- list(3,0,1.34^2)ff <-"power"samples.alpha <- getprior(prior.alpha,2000)mtd <- find.x(ff, target.tox, alpha=samples.alpha)hist(mtd)## Standardised dosessdose <- find.x(ff, p.tox0, alpha=1)## Posterior distribution of the MTD (on standardised dose scale) using data ## from the cancer trial described in Neuenschwander et al 2008.## Using R2WinBUGS## Not run:posterior.samples <- Posterior.R2WinBUGS(tox, notox, sdose, ff, prior.alpha
, burnin.itr=2000, production.itr=2000, bugs.directory ="C:/Program Files/WinBUGS14/")## End(Not run)
References
Sweeting M., Mander A., Sabin T. bcrm: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials. Journal of Statistical Software (2013) 54: 1--26. http://www.jstatsoft.org/article/view/v054i13
See Also
bcrm, find.x
Author(s)
Michael Sweeting mjs212@medschl.cam.ac.uk (University of Cambridge, UK), drawing on code originally developed by J. Jack Lee and Nan Chen, Department of Biostatistics, the University of Texas M. D. Anderson Cancer Center